Olema Pharmaceuticals, Inc.
OLMA
$27.45
$0.301.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.61M | 17.08M | 17.53M | 17.74M | 18.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 155.38M | 147.13M | 142.79M | 137.26M | 133.71M |
| Operating Income | -155.38M | -147.13M | -142.79M | -137.26M | -133.71M |
| Income Before Tax | -149.96M | -142.30M | -128.89M | -129.47M | -122.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -149.96 | -142.30 | -128.89 | -129.47 | -122.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -149.96M | -142.30M | -128.89M | -129.47M | -122.68M |
| EBIT | -155.38M | -147.13M | -142.79M | -137.26M | -133.71M |
| EBITDA | -154.96M | -146.66M | -142.36M | -136.87M | -133.34M |
| EPS Basic | -1.87 | -1.98 | -2.01 | -2.21 | -2.19 |
| Normalized Basic EPS | -1.10 | -1.17 | -1.26 | -1.33 | -1.34 |
| EPS Diluted | -1.87 | -1.98 | -2.01 | -2.21 | -2.19 |
| Normalized Diluted EPS | -1.10 | -1.17 | -1.26 | -1.33 | -1.34 |
| Average Basic Shares Outstanding | 322.45M | 293.98M | 264.76M | 234.91M | 223.90M |
| Average Diluted Shares Outstanding | 322.45M | 293.98M | 264.76M | 234.91M | 223.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |